Edit |   |
---|---|
Antigenic Specificity | CD3E & EpCAM, Human (Catumaxomab biosimilar) |
Clone | Catumaxomab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2a kappa/G2b lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD3E & EpCAM Recombinant Antibody (Catumaxomab). Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in people with metastasizing cancer. It binds to antigens CD3 and EpCAM. It was developed by Fresenius Biotech and Trion Pharma (Germany). |
Immunogen | n/a |
Other Names | Anti-CD3E & EpCAM Recombinant Antibody, Research Grade Catumaxomab, Anti-Human CD3E & EpCAM Recombinant Antibody(Catumaxomab), Musmus G2a kappa, anti-EPCAM (Ho-3/TP-A-01)/Rat sp.G2b lambda, Antibody Drug Analogues, Monoclonal Antibody, YR1139, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 509077-98-9 |
Catalog # | YR1139 |
Price | please inquire |
Order / More Info | CD3E & EpCAM, Human (Catumaxomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |